1. Home
  2. HZO vs RCKT Comparison

HZO vs RCKT Comparison

Compare HZO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MarineMax Inc.  (FL)

HZO

MarineMax Inc. (FL)

N/A

Current Price

$26.41

Market Cap

591.7M

ML Signal

N/A

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

N/A

Current Price

$4.30

Market Cap

534.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HZO
RCKT
Founded
1998
1999
Country
United States
United States
Employees
N/A
202
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
591.7M
534.2M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
HZO
RCKT
Price
$26.41
$4.30
Analyst Decision
Strong Buy
Buy
Analyst Count
3
14
Target Price
$30.00
$29.65
AVG Volume (30 Days)
434.3K
2.9M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,309,288,000.00
N/A
Revenue This Year
$3.02
N/A
Revenue Next Year
$4.04
$97.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.85
$2.19
52 Week High
$32.00
$8.80

Technical Indicators

Market Signals
Indicator
HZO
RCKT
Relative Strength Index (RSI) 45.91 48.12
Support Level $24.44 $4.16
Resistance Level $28.13 $4.51
Average True Range (ATR) 1.37 0.33
MACD -0.14 -0.11
Stochastic Oscillator 38.82 14.44

Price Performance

Historical Comparison
HZO
RCKT

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: